---All---
  • ---All---
  • Accession
  • Catalog #

HNRNPH2 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP13497b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP13497b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

HNRNPH2 Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP55795
Other AccessionQ6AY09, P70333, Q3SZF3, Q8VHV7, O35737, P31943, NP_001027565.1, NP_062543.1
ReactivityHuman
PredictedBovine, Mouse, Rat
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW49264 Da

HNRNPH2 Antibody (C-term) - Additional info

Gene ID 3188
Other Names
HNRNPH2; FTP3; HNRPH2; Heterogeneous nuclear ribonucleoprotein H2; FTP-3; Heterogeneous nuclear ribonucleoprotein H'
Target/Specificity
This HNRNPH2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 310-340 amino acids from the C-terminal region of human HNRNPH2.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
HNRNPH2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

HNRNPH2 Antibody (C-term) - Protein Information

Name HNRNPH2
Synonyms FTP3, HNRPH2
Function
This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Binds poly(RG)
Cellular Location
Nucleus, nucleoplasm.
Tissue Location
Expressed ubiquitously.

HNRNPH2 Antibody (C-term) - Related products

AP13497b: HNRNPH2 Antibody (C-term)

DC14613: Human HNRNPH2 cDNA Clone

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has three repeats of quasi-RRM domains that binds to RNAs. It is very similar to the family member HNRPH1. This gene is thought to be involved in Fabray disease and X-linked agammaglobulinemia phenotype. Alternative splicing results in multiple transcript variants encoding the same protein.

REFERENCES

Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009) Maggi, L.B. Jr., et al. Mol. Cell. Biol. 28(23):7050-7065(2008) Miyasaka, T., et al. Cancer Sci. 99(4):755-761(2008) Olsen, J.V., et al. Cell 127(3):635-648(2006)